Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

BACKGROUND: Malignant pleural mesothelioma is an aggressive tumor that has a poor prognosis and is resistant to unimodal approaches. Multimodal treatment has provided encouraging results. METHODS: Phase II, open-label study of the combination of chemotherapy (pemetrexed 500 mg/m(2)+cisplatin 75 mg/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Federico, Rea, Adolfo, Favaretto, Giuseppe, Marulli, Lorenzo, Spaggiari, Martino, DePas Tommaso, Anna, Ceribelli, Adriano, Paccagnella, Gino, Crivellari, Francesca, Russo, Matteo, Ceccarelli, Gbenga, Kazeem, Paolo, Marchi, Francesco, Facciolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722081/
https://www.ncbi.nlm.nih.gov/pubmed/23324131
http://dx.doi.org/10.1186/1471-2407-13-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722081/
https://www.ncbi.nlm.nih.gov/pubmed/23324131
http://dx.doi.org/10.1186/1471-2407-13-22

Ejemplares similares